GLINTA-M 2.5 mg + 850 mg TABLET contains Linagliptin 2.5 mg + Metformin Hydrochloride 850 mg. It is a combination antidiabetic medicine (DPP-4 inhibitor + biguanide) used for the treatment of type 2 diabetes mellitus to improve blood glucose control.
Uses:
Treatment of type 2 diabetes mellitus
Improves blood glucose control along with diet and exercise
Used when treatment with both Linagliptin and Metformin Hydrochloride is appropriate
Helps reduce the risk of diabetes-related complications by maintaining blood glucose levels
Dose:
Usually one tablet twice daily, or as prescribed by the physician
Take the tablet with meals to reduce gastrointestinal side effects
Swallow the tablet whole with water and take it at the same times each day
Dose and duration should be adjusted according to the patient's blood glucose levels, kidney function, and response to treatment